Omni Partners

Latest statistics and disclosures from Omni Partners's latest quarterly 13F-HR filing:

  • Omni Partners was a net seller of stock by $0.

Companies in the Omni Partners portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Kite Pharma 15.19 661711 179.81
Time Warner (TWX) 11.82 903465 102.45
Rice Energy 10.63 2.88M 28.94
Calpine Corporation (CPN) 8.48 4.50M 14.75
Nxp Semiconductors N V 8.31 575486 113.09
Level 3 Communications 6.47 951789 53.27
Neuroderm Ltd F 5.55 1.12M 38.90
PAREXEL International Corporation (PRXL) 5.32 472903 88.08
Alere (ALR) 4.64 711971 50.99
C.R. Bard (BCR) 4.42 108130 320.49
Fortress Investment (FIG) 3.95 3.86M 8.01
Advisory Board Company (ABCO) 3.50 510735 53.62
Fidelity + Guaranty Life 1.87 470939 31.05
Altaba 1.80 213057 66.24
Akorn (AKRX) 1.64 386572 33.19
Scripps Networks Interactive (SNI) 1.47 134044 85.89
NxStage Medical (NXTM) 1.19 337893 27.60
Brocade Communications Systems (BRCD) 1.02 668211 11.95
Quidel Corporation (QDEL) 0.82 146189 43.86
Dominion Diamond Corp foreign stock 0.56 306879 14.18
Paratek Pharmaceuticals 0.47 147700 25.10
Discovery Communications (DISCK) 0.45 175586 20.26
Colgate-Palmolive Company (CL) 0.41 44454 72.84
Pandora Media Inc 0.03 26001 7.69

Past 13F-HR SEC Filings by Omni Partners

View All Filings